These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10639304)

  • 1. Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide).
    Klamann A; Sarfert P; Launhardt V; Schulte G; Schmiegel WH; Nauck MA
    Eur Heart J; 2000 Feb; 21(3):220-9. PubMed ID: 10639304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits.
    Nieszner E; Posa I; Kocsis E; Pogátsa G; Préda I; Koltai MZ
    Exp Clin Endocrinol Diabetes; 2002 Aug; 110(5):212-8. PubMed ID: 12148084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-hospital mortality after acute myocardial infarction in patients with diabetes mellitus.
    Chyun D; Obata J; Kling J; Tocchi C
    Am J Crit Care; 2000 May; 9(3):168-79. PubMed ID: 10800601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry.
    Danchin N; Charpentier G; Ledru F; Vaur L; Guéret P; Hanania G; Blanchard D; Lablanche JM; Genès N; Cambou JP
    Diabetes Metab Res Rev; 2005; 21(2):143-9. PubMed ID: 15386810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glibenclamide on ventricular fibrillation in non-insulin-dependent diabetics with acute myocardial infarction.
    Lomuscio A; Vergani D; Marano L; Castagnone M; Fiorentini C
    Coron Artery Dis; 1994 Sep; 5(9):767-71. PubMed ID: 7858767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of a history of diabetes on treatment and outcome in acute myocardial infarction, during two time periods and in two different countries.
    Svensson AM; Dellborg M; Abrahamsson P; Karlsson T; Herlitz J; Duval SJ; Berger AK; Luepker RV
    Int J Cardiol; 2007 Jul; 119(3):319-25. PubMed ID: 17067706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction.
    Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):121-6. PubMed ID: 17346952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Warm-up' phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas.
    Bilinska M; Potocka J; Korzeniowska-Kubacka I; Piotrowicz R
    Coron Artery Dis; 2007 Sep; 18(6):455-62. PubMed ID: 17700217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: comparison between patients receiving sulfonylureas and insulin.
    Tentolouris N; Matsagura M; Psallas M; Chatzizacharias A; Fotia M; Arvanitis M; Katsilambros N
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):298-301. PubMed ID: 15926117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of blood glucose in diabetic patients with acute myocardial infarction.
    Fava S; Aquilina O; Azzopardi J; Agius Muscat H; Fenech FF
    Diabet Med; 1996 Jan; 13(1):80-3. PubMed ID: 8741817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodromal unstable angina in acute myocardial infarction: prognostic value of short- and long-term outcome and predictor of infarct size.
    Bahr RD; Leino EV; Christenson RH
    Am Heart J; 2000 Jul; 140(1):126-33. PubMed ID: 10874273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcome of diabetic patients with acute myocardial infarction. Data from the BLITZ-1 study.
    Casella G; Savonitto S; Chiarella F; Gonzini L; Di Chiara A; Bolognese L; De Servi S; Greco C; Zonzin P; Coccolini S; Maggioni AP; Boccanelli A;
    Ital Heart J; 2005 May; 6(5):374-83. PubMed ID: 15934409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short and long-term outcome in diabetic patients with acute myocardial infarction in the invasive era.
    Hansen HH; Joensen AM; Riahi S; Malczynski J; Mølenberg D; Ravkilde J
    Scand Cardiovasc J; 2007 Jan; 41(1):19-24. PubMed ID: 17365973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfonylureas and mortality in diabetic patients after myocardial infarction.
    Brady PA; Al-Suwaidi J; Kopecky SL; Terzic A
    Circulation; 1998 Feb; 97(7):709-10. PubMed ID: 9495313
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.
    Timmer JR; Ottervanger JP; de Boer MJ; Boersma E; Grines CL; Westerhout CM; Simes RJ; Granger CB; Zijlstra F;
    Arch Intern Med; 2007 Jul; 167(13):1353-9. PubMed ID: 17620527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group.
    Gustafsson I; Hildebrandt P; Seibaek M; Melchior T; Torp-Pedersen C; Køber L; Kaiser-Nielsen P
    Eur Heart J; 2000 Dec; 21(23):1937-43. PubMed ID: 11071799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of diabetes mellitus on in-hospital mortality in patients with acute myocardial infarction in Japan: a report from TAMIS-II.
    Hirakawa Y; Masuda Y; Kuzuya M; Iguchi A; Kimata T; Uemura K
    Diabetes Res Clin Pract; 2007 Jan; 75(1):59-64. PubMed ID: 16762440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.
    Yngen M; Ostenson CG; Hjemdahl P; Wallén NH
    Diabet Med; 2006 Feb; 23(2):134-40. PubMed ID: 16433710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.